Primary Investigator:
Angelo Ferraro MD Michael Ring MD

Description:
This study examines the safety and effectiveness of the TAXUS Liberte'-SR stent in patients with symptomatic heart disease. After determination of eligibility including coronary angiography, all participants will receive the Liberte'-SR drug-eluting stent coated with paclitaxel. Only one heart artery may be treated with the study stent.  Participants will be followed for 5 years.

Eligibility:

• Age 18 years or older
• Have stable or unstable angina
• Meet angiographic criteria as determined by heart angiogram
• Other eligibility criteria may apply. Please contact study coordinator.

Exclusions:

• Unable to take aspirin or Plavix
• Other exclusion criteria may apply. Please contact study coordinator.

Study Timeline:
Closed to enrollment

Study Contact:
Debbie, CCRC Debbie.Westover@providence.org

Study Sponsor:
Boston Scientific Corporation